For many years, researchers have argued that preeclampsia is a clinical syndrome of the placenta resulting from an immune response to the foreign organ. The theory is that preeclampsia typically presents with symptoms affecting the blood vessels, such as hypertension, proteinuria, and organ dysfunction, but is actually the result of earlier inflammation, endothelial damage (damage that affects the interior lining of the blood vessels), and reduced blood flow to vital organs.
This research article asks the question: is the placenta the reason preeclampsia occurs, or is it just one more organ affected by an underlying cardiovascular disease? The authors make the argument that preeclampsia could be caused by an underlying cardiovascular disease which is not yet fully understood, with the placental issues only being a secondary effect (along with other organs). Proposing that preeclampsia starts with cardiovascular issues could then influence how preeclampsia screening, diagnostic and prevention strategies would be managed by a woman’s care providers. Given the annual impact the disease has on pregnancies in the US and globally, this viewpoint could help increase focus on prevention strategies.
Take home message: A clear understanding and acceptance of the role of the cardiovascular system in preeclampsia is needed.
Link: https://www.ajog.org/article/S0002-9378(20)31198-4/fulltext
Each quarter, our team of researchers reviews the most current studies related to hypertensive disorders of pregnancy and selects those studies they feel will be of greatest interest to our community to summarize.
Special thanks to our volunteer research team, who under the leadership of Dr. Elizabeth Sutton, make Research Roundup possible: Alisse Hauspurg, MD Felicia LeMoine, MD Jenny Sones, PhD, DVM, and Robin Trupp, PhD, RN.
A new research study suggests that blood pressure changes during the first 20 weeks of pregnancy—called blood pressure trajectories—may give providers a peek at a woman’s risk of dev...
Preeclampsia is a major cause of maternal and fetal morbidity and mortality. Prompt and accurate diagnosis is necessary to prevent adverse outcomes. A study was completed to determine the accura...
Predicting preeclampsia has proven to be a challenge. Researchers have documented many differences in early pregnancy between those who eventually develop preeclampsia and those who do not. These incl...
The U.S. Preventive Services Task Force (USPSTF) and American College of Obstetricians and Gynecologists (ACOG) guidelines changed in 2021 to help prevent preeclampsia. Low-dose aspirin has been shown...
Hypertensive disorders of pregnancy (HDP), including preeclampsia, affect 1 in 6 pregnancies. HDP is a general term for a range of mild to severe outcomes. Until now there has not been a reliabl...